IPG Photonics (IPGP) 47th Annual Raymond James Institutional Investor Conference summary

Business overview and strategic direction

• Focus on industrial applications like metal cutting, welding, additive manufacturing, and cleaning, with expansion into medical, micromachining, and defense markets.

• Significant organizational restructuring, building a new leadership team and implementing scalable processes.

• Expansion into new markets is expected to add $4–5 billion in total addressable market (TAM), especially in medical, micromachining, and defense.

• Go-to-market strategies and structured product development processes have been optimized for growth.

• Business is now more regionally balanced across global markets.

Market performance and outlook

• 2025 marked the first year of growth since 2021, with strong Q4 results and a book-to-bill ratio above one heading into 2026.

• Purchasing Managers' Index (PMI) indicators are positive in the US, China, Japan, and Europe, signaling industrial recovery.

• Differentiation in core markets through new high-power, cost-effective laser platforms and strong service infrastructure.

• Expectation to outgrow industrial markets due to unique technology and solutions.

• Cautious optimism for 2026, supported by innovation and regional market improvements.

Product innovation and new markets

• Launched a commercial counter-drone system in late 2025, targeting both defense and civilian infrastructure, with early adoption by Lockheed Martin.

• Medical market focus on urology, especially lithotripsy, with recurring revenue from disposable fibers and new product launches like StoneSense.

• Roadmap for medical products extends through 2027, targeting a $2 billion TAM.

• Acquisition of cleanLASER in 2024 enhanced capabilities in the industrial cleaning market, leading to product and go-to-market synergies.

• Successful integration of cleanLASER has resulted in better-than-expected performance and sets up future M&A opportunities.